Back

Hemodynamic and anti-remodelling effect of the rho kinase inhibitor y-27632 in monocrotaline pulmonary arterial hypertension rat model

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Basic mechanisms in pulmonary hypertension Chronic pulmonary hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Silvia Cantoni

R&D Chiesi Farmaceutici S.P.A., Parma (Italy)

6 More presentations in this session

Presentation thumbnail
A new experimental model of pulmonary arterial hypertension- KDR knock out
Doctor M. Winter (Vienna, AT)
Abstract Slides
Presentation thumbnail
Hypoxia induces the downregulation of the BMP signalling in pulmonary artery smooth muscle cells through the endothelin system
Doctor H. Maruyama (Tsuchiura, JP)
Abstract Slides
Presentation thumbnail
Preventive effects of novel urotensin II receptor antagonist in experimental pulmonary arterial hypertension
Doctor B. Lee (Daejeon, KR)
Abstract Slides
Presentation thumbnail
Hypoxia-induced pulmonary hypertension is attenuated by hypoxia-inducible factor-1 alpha deletion in macrophage
Mr H. Kojima (Fukuoka, JP)
Abstract Slides
Presentation thumbnail
Levosimendan prevents and reverts pressure-overload induced right ventricular failure.
Miss M. Hansen (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
Basic mechanisms in pulmonary hypertension

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources